Bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae among patients with malignancy: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae among patients with malignancy: a systematic review and meta-analysis

Published:2017-11 Issue:5 Volume:50 Page:657-663
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Alevizakos Michail,Gaitanidis Apostolos,Andreatos Nikolaos,Arunachalam Karuppiah,Flokas Myrto Eleni,Mylonakis Eleftherios

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference45 articles.

1. Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella spp.: a systematic review and meta-analyses;Hendrik;PLoS ONE,2015

2. Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections;Trecarichi;Future Microbiol,2012

3. Colonization and infection with extended spectrum β-lactamase producing Enterobacteriaceae in high-risk patients—review of the literature from a clinical perspective;Biehl;Crit Rev Microbiol,2016

4. Infections caused by extended-spectrum β-lactamases producing Enterobacteriaceae: clinical and economic impact in patients hospitalized in 2 teaching hospitals in Dakar, Senegal;Ndir;Antimicrob Resist Infect Control,2016

5. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations;Hutton;Ann Intern Med,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of a Prognostic Model for Multi-Drug-Resistant Non-Hospital-Acquired Bloodstream Infection;Antibiotics;2023-05-24

2. Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models;BMC Infectious Diseases;2023-04-18

3. Risk factor modelling of antimicrobial resistance in cancer patients: A systematic review;2022-09-28

4. Clinical outcomes of antimicrobial resistance in cancer patients: A systematic review of multivariable models;2022-07-17

5. Plasmid-mediated antimicrobial resistance in drinking water;Environmental Advances;2022-07